These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 38051891)

  • 41. Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease.
    Marcus JN; Schachter J
    J Neurogenet; 2011 Dec; 25(4):127-33. PubMed ID: 22091726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.
    Shukla V; Skuntz S; Pant HC
    Arch Med Res; 2012 Nov; 43(8):655-62. PubMed ID: 23142263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
    Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer's Disease and Identifying Promising Drug Targets.
    Fišar Z
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of neuroinflammation in Alzheimer's disease via nanoparticle-loaded phytocompounds with anti-inflammatory and autophagy-inducing properties.
    Nayak V; Patra S; Rout S; Jena AB; Sharma R; Pattanaik KP; Singh J; Pandey SS; Singh RP; Majhi S; Singh KR; Kerry RG
    Phytomedicine; 2024 Jan; 122():155150. PubMed ID: 37944239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
    Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurobiology of Alzheimer's disease.
    Mohandas E; Rajmohan V; Raghunath B
    Indian J Psychiatry; 2009 Jan; 51(1):55-61. PubMed ID: 19742193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cellular factors modulating the mechanism of tau protein aggregation.
    Fontaine SN; Sabbagh JJ; Baker J; Martinez-Licha CR; Darling A; Dickey CA
    Cell Mol Life Sci; 2015 May; 72(10):1863-79. PubMed ID: 25666877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders.
    Polis B; Samson AO
    Neural Regen Res; 2020 Aug; 15(8):1460-1470. PubMed ID: 31997805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration.
    Zafar S; Fatima SI; Schmitz M; Zerr I
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early but not late conformational changes of tau in association with ubiquitination of neurofibrillary pathology in Alzheimer's disease brains.
    Ibarra-Bracamontes VJ; Escobar-Herrera J; Kristofikova Z; Rípova D; Florán-Garduño B; Garcia-Sierra F
    Brain Res; 2020 Oct; 1744():146953. PubMed ID: 32526294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer's Disease.
    Yin X; Qiu Y; Zhao C; Zhou Z; Bao J; Qian W
    Med Sci Monit; 2021 Sep; 27():e933084. PubMed ID: 34471085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation.
    Chen Y; Yu Y
    J Neuroinflammation; 2023 Jul; 20(1):165. PubMed ID: 37452321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Unifying Hypothesis for Alzheimer's Disease: From Plaques to Neurodegeneration.
    Edwards FA
    Trends Neurosci; 2019 May; 42(5):310-322. PubMed ID: 31006494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments.
    Seyedaghamiri F; Rajabi M; Mohaddes G
    Neurochem Res; 2023 Jan; 48(1):26-38. PubMed ID: 36048350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease.
    Madav Y; Wairkar S; Prabhakar B
    Brain Res Bull; 2019 Mar; 146():171-184. PubMed ID: 30634016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New age of neuroproteomics in Alzheimer's disease research.
    Kovacech B; Zilka N; Novak M
    Cell Mol Neurobiol; 2009 Sep; 29(6-7):799-805. PubMed ID: 19225878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathological Changes of Tau Related to Alzheimer's Disease.
    Chu D; Liu F
    ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
    Navarrete LP; Pérez P; Morales I; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.